Hepatocellular carcinoma.

Abstract

HepatologyVolume 28, Issue 4 p. 1161-1165 Meeting ReportFree Access Hepatocellular carcinoma Adrian M. Di Bisceglie, Corresponding Author Adrian M. Di Bisceglie DIBISCAM@WPOGATE.SLU.EDU Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, MODepartment of Internal Medicine, St. Louis University School of Medicine, 1402 S. Grand Blvd., St. Louis, MO 63124. Fax: (314) 268-5108===Search for more papers by this authorRobert L. CARITHERS JR., Robert L. CARITHERS JR. Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, MOSearch for more papers by this authorGregory J. Gores, Gregory J. Gores Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, MOSearch for more papers by this author Adrian M. Di Bisceglie, Corresponding Author Adrian M. Di Bisceglie DIBISCAM@WPOGATE.SLU.EDU Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, MODepartment of Internal Medicine, St. Louis University School of Medicine, 1402 S. Grand Blvd., St. Louis, MO 63124. Fax: (314) 268-5108===Search for more papers by this authorRobert L. CARITHERS JR., Robert L. CARITHERS JR. Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, MOSearch for more papers by this authorGregory J. Gores, Gregory J. Gores Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, MOSearch for more papers by this author First published: 30 December 2003 https://doi.org/10.1002/hep.510280436Citations: 129AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References 1 Sherman M, Peltekian KM, Lee C. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology 1995; 22: 432– 438.MEDLINE 2 Miller WJ, Baron RL, Dodd GD, Federle MP. Malignancies in patients with cirrhosis: CT sensitivity and specificity in 200 consecutive transplant patients. Radiology 1994; 193: 645– 650.MEDLINE 3 Chen H-L, Chang M-H, Ni Y-H, Hsu H-Y, Lee P-I, Lee C-Y, Chen D-S. Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan. JAMA 1996; 276: 906– 908.MEDLINE 4 Chang M-H, Chen C-J, Lai M-S, Hsu H-M, Wu T-C, Kong M-S, Liang D-C, et al. , and the childhood hepatoma study group. Universal hepatitis B vaccination in Taiwan and incidence of hepatocellular carcinoma in children. N Engl J Med 1997; 336: 1855– 1859.MEDLINE 5 Nishiguchi S, Kuroki T, Nakatani S, Morimoto H, Takeda T, Nakajima S, Shiomi S, et al. Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 1995; 346: 1051– 1055.MEDLINE 6 Mazzella G, Accogli E, Sottili S, Kesti D, Orsini M, Salzetta A, Novelli V, et al. Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis. J Hepatol 1996; 24: 141– 147.MEDLINE 7 Jacobson LP, Zhang B-C, Zhu Y-R, Wang J-B, Wu Y, Zhang Q-N, Yu L-Y, et al. Oltipraz chemoprevention trial in Qidong, People's Republic of China: study design and clinical outcomes. Cancer Epidemiol Biomarkers Prev 1997; 6: 257– 265.MEDLINE 8 Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, Takasaki KT, Tanaka T, et al. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. N Engl J Med 1996; 334: 1561– 1567.MEDLINE Citing Literature Volume28, Issue4October 1998Pages 1161-1165 ReferencesRelatedInformation